LeMaitre Vascular Valuation Multiples

LeMaitre Vascular Overview

About LeMaitre Vascular

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.

Founded

1983

HQ

Employees

664

Website

lemaitre.com

Sectors

Medical DevicesDeepTechHealthTech

Financials (LTM)

Revenue: $259M

EBITDA: $79M

EV

$2B

Valuation Multiples

Multiples.vc

Start free trial

LeMaitre Vascular Financials

LeMaitre Vascular reported last 12-month revenue of $259M and EBITDA of $79M.

In the same LTM period, LeMaitre Vascular generated $184M in gross profit, $79M in EBITDA, and $61M in net income.

LeMaitre Vascular P&L

In the most recent fiscal year, LeMaitre Vascular reported revenue of $250M and EBITDA of $91M.

LeMaitre Vascular expects next 12-month revenue of XXX and NTM EBITDA of XXX

LeMaitre Vascular Stock Performance

LeMaitre Vascular has current market cap of $3B, and enterprise value of $2B.

LeMaitre Vascular's stock price is $114.33.

LeMaitre Vascular Valuation Multiples

LeMaitre Vascular trades at 9.4x EV/Revenue multiple, and 30.9x EV/EBITDA.

LeMaitre Vascular Financial Valuation Multiples

As of April 19, 2026, LeMaitre Vascular has market cap of $3B and EV of $2B.

Equity research analysts estimate LeMaitre Vascular's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

LeMaitre Vascular has a P/E ratio of 43.2x.

LeMaitre Vascular Margins & Growth Rates

LeMaitre Vascular's revenue in the last 12 month grew by 11%.

LeMaitre Vascular's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.2M for the same period.

LeMaitre Vascular's rule of 40 is 44% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

LeMaitre Vascular's rule of X is 62% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

LeMaitre Vascular Public Comps

See public comps and valuation multiples for other Medical Devices comps.

LeMaitre Vascular M&A Activity

LeMaitre Vascular acquired XXX companies to date.

Last acquisition by LeMaitre Vascular was on XXXXXXXX, XXXXX. LeMaitre Vascular acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

LeMaitre Vascular Investment Activity

LeMaitre Vascular invested in XXX companies to date.

LeMaitre Vascular made its latest investment on XXXXXXXX, XXXXX. LeMaitre Vascular invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).